ResMed’s shares were up as much as 2.5% in the trading session following the news release. The stock eventually closed at $51.29 yesterday, gaining around 2.2%. Per the ruling, the APEX XT and iCH ...

Recently, ResMed ( RMD) filed parallel lawsuits in the International Trade Commission (ITC) and U.S. federal court to protect its patent landscape from its international competitor APEX Medical. This ...